Weight loss and blood pressure normalization: The relevance of early interventions in hypertension

Hypertension Research

Volumn 33, Issue 3, 2010, Pages 195-196

  Cicero, Arrigo F G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; TETRAHYDROLIPSTATIN;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DOSE CALCULATION; DOSE RESPONSE; EARLY INTERVENTION; HEALTH CARE POLICY; HUMAN; HYPERTENSION; INCIDENCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LOW CALORY DIET; METABOLIC SYNDROME X; NOTE; OBESITY; PATIENT COMPLIANCE; PUBLIC HEALTH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BLOOD PRESSURE; BODY MASS INDEX; HUMANS; HYPERTENSION; LACTONES; WEIGHT LOSS;

EID: 77749246311     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.227     Document Type: Note

References (10)

1. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009; 302: 401-411.
2. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6: e1000058.
3. O'Keefe JH, Carter MD, Lavie CJ. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 2009; 84: 741-757.
4. Fodor GJ, McInnis NH, Helis E, Turton P, Leenen FH. Lifestyle changes and blood pressure control: a community-based cross-sectional survey (2006 Ontario Survey on the Prevalence and Control of Hypertension). J Clin Hypertens 2009; 11: 31-35.
5. Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D. Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review. Hypertension 2009; 54: 756-762.
6. Fogari R, Zoppi A, Corradi C, Preti P, Mugellini A, Lazzari P, Derosa G. Effect of body weight loss and normalization on blood pressure in overweight non obese patients with stage 1 hypertension. Hypertension Research 2010; 33: 236-242.
7. Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008; 117: 3238-3249.
8. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119: 628-647.
9. Marquez-Celedonio FG, Texon-Fernandez O, Chavez-Negrete A, Hernandez-Lopez S, Marín-Rendon S, Berlín-Lascuraina S. Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study. Rev Esp Cardiol 2009; 62: 86-90.
10. Siebenhofer A, Horvath K, Jeitler K, Berghold A, Stich AK, Matyas E, Pignitter N, Siering U. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2009; Art. No. CD007654.